Here is What Hedge Funds Think About Deciphera Pharmaceuticals, Inc. (DCPH)
A whopping number of 13F filings filed with U.S.
Deciphera Pharmaceuticals Inc. (DCPH)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 5,836,000 | $54,100 | +71% | 1.04% |
| 2. | Deerfield Management James E. Flynn | 5,580,456 | $51,731 | 1.15% | |
| 3. | Redmile Group Jeremy Green | 664,817 | $6,163 | 0.19% | |
| 4. | Millennium Management Israel Englander | 576,298 | $5,342 | -32% | 0% |
| 5. | Laurion Capital Management Benjamin A. Smith | 459,290 | $4,258 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.00 | 1,478,978 | Large Shareholder | 18,051,348 | 2022-04-29 | Filing | |
| $17.00 | 375,000 | Large Shareholder | 2,146,308 | 2017-10-02 | Filing | |
| $17.00 | 375,000 | Large Shareholder, Director | 2,146,308 | 2017-10-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.05 | 1,366 | Officer | 47,866 | 2022-02-16 | Filing | |
| $9.05 | 1,146 | Officer | 48,668 | 2022-02-16 | Filing | |
| $9.05 | 984 | Officer | 76,790 | 2022-02-16 | Filing | |
| $9.05 | 1,368 | Officer | 47,848 | 2022-02-16 | Filing | |
| $9.05 | 1,146 | Officer | 37,959 | 2022-02-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 44,674 | $414,129 | 0% | |
| 2. | 23,557 | $218,373 | 0% | |
| 3. | 5,738,770 | $53,198 | 0% | |
| 4. | 4,845,376 | $44,917 | 0% | |
| 5. | 3,594,512 | $33,321 | 0% |
News See All
5 Best Fast Growth Stocks to Buy Now
Revolve Group, Inc. (NYSE:RVLV) is an online fashion retailer.
5 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Deciphera Pharmaceuticals, Inc. (DCPH) Fell Out Of Favor With Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
15 Stocks that Will Double In 2021
The economy of 2020 was closely linked to the COVID-19 pandemic. However, the vaccine rollout at the turn of the year buoyed hopes of a return to normalcy and an accelerated recovery from the virus.
Hedge Funds Aren’t Crazy About Deciphera Pharmaceuticals, Inc. (DCPH) Anymore
In this article we will take a look at whether hedge funds think Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) is a good investment right now.
Is DCPH Stock A Buy or Sell?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
DCPH Stock Forecast: Where Do Hedge Funds Stand?
In this article you are going to find out whether hedge funds think Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) is a good investment right now.
Hedge Funds Never Been This Bullish On Deciphera Pharmaceuticals, Inc. (DCPH)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Did Hedge Funds Make The Right Call On Deciphera Pharmaceuticals, Inc. (DCPH) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
